Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytosorbents Corp (NASDAQ:CTSO)

4.30
Delayed Data
As of Jun 23
 +0.20 / +4.88%
Today’s Change
3.30
Today|||52-Week Range
6.90
-21.10%
Year-to-Date
No recent news for Cytosorbents Corp.

Today’s Trading

Previous close4.10
Today’s open4.15
Day’s range4.00 - 4.35
Volume76,066
Average volume (3 months)146,257
Market cap$120.9M
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-42.42%
Earnings growth (this year)+40.43%
Earnings growth (next 5 years)--
Revenue growth (last year)+98.84%
P/E ratioNM
Price/Sales14.55
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CDTXCidara Therapeutics ...-0.20-2.90%
CDXCChromadex Corp-0.04-1.09%
MTPMidatech Pharma PLC-0.13-4.93%
LFVNLifeVantage Corp+0.03+0.72%
Data as of 4:00pm ET, 06/23/2017

Financials

Next reporting dateAugust 16, 2017
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$9.5M
Annual profit (last year)-$11.9M
Net profit margin-125.31%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Phillip P. Chan
Chief Operating Officer
Vincent Capponi
Corporate headquarters
Monmouth Junction, New Jersey

Forecasts